J A van Burik1, R Colven, D H Spach. Show Affiliations » 1. Department of Medicine, University of Washington School of Medicine, Seattle, USA.
Abstract
Entities: Chemical Disease Species
Mesh： See more » AIDS-Related Opportunistic Infections/drug therapyAIDS-Related Opportunistic Infections/immunologyAIDS-Related Opportunistic Infections/pathologyAntifungal Agents/therapeutic useAspergillosis/complicationsAspergillosis/drug therapyAspergillosis/immunologyAspergillosis/pathologyCD4 Lymphocyte CountDermatomycoses/complicationsDermatomycoses/drug therapyDermatomycoses/immunologyHumansItraconazole/therapeutic use
Substances： See more » Antifungal AgentsItraconazole
Year: 1998 PMID： 9770169 DOI： 10.1086/517138
Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079